Search results for: Reg a+
-
1
How to Cope With a Lack of Startup Updates
I was very excited when I first began online angel investing in 2014. I loved the concept. So I invested in 15 deals within just a few months on AngelList and FundersClub. I thought they were high quality picks. And I eagerly waited to see how they would do. But after a few months, I realized the startups weren’t giving…
-
2
Crowdfunding Keeps Getting Better Four Years In
Crowdfunding celebrated its fourth anniversary last week. The SEC greenlit it on May 16, 2016. A year before Regulation Crowdfunding (better known as Reg. CF) began, the SEC began to allow companies to raise funds under Regulation A+ (Reg. A+). But startups needed considerable money and time to comply with SEC requirements for Reg. A+. Deal flow was slow and…
-
3
Not All Hot Sectors Have Staying Power
In today’s world of quarantines and lockdowns, there’s a huge divide between winners and losers. Brick-and-mortar retail, travel, and construction are all getting hammered. But some sectors are still thriving. Today we’re going to take a look at a few of them — and discuss whether they’re worth investing in for the long-term. Telemedicine Soars Since the lockdowns began, telemedicine…
-
4
Invest in the Startup That Helps Doctors Make Better Decisions
Deal Details Startup: Elemeno Health Security type: Crowd SAFE Discount: 0% Valuation (cap): $12 million Minimum investment: $100 Where to invest: Republic Deadline: September 16, 2020 View Elemeno Health’s latest 2024 funding round analysis on Kingscrowd here. Timing is everything — especially in investing. And the startup I’m recommending you invest in today has perfect timing. The influx of COVID-19…
-
5
New Crowdfunding Rules Bring New Opportunities
Economic crises can reveal a lot about established companies. Are they nimble enough to pivot? Can they come up with creative solutions to adapt to a new environment? Was the company prepared for an emergency? Apple and Google were sitting on a pile of cash. They were definitely prepared for a crisis. GM figured out how to help produce masks…
-
6
Can Coronavirus Antibody Tests Save the U.S.?
My sister sent me an urgent text recently… “I need to know ASAP if you’re interested in getting antibody tests. No promises but need to know your interest in the next few moments…” Her son knew somebody who could possibly get his hands on some. I answered immediately. “I need them for my wife, my kids and their spouses. So…
-
7
Invest in the Startup That Created the First Saliva Test for Autism
COVID-19 has shone a bright light on the critical need for testing and diagnosing in our healthcare system. As a nation grappling with more than 1 million (and counting) confirmed COVID-19 cases, we have come to understand the vast difference between suspecting you have an illness and knowing for sure. But COVID-19 is not the only illness lacking proper testing.…
-
8
Webinar: Meet Ample Foods Founder Connor Young
When we first recommended you invest in Ample Foods more than a year ago, the healthy meal replacement company was an intriguing startup with a ton of potential. As consumers became more conscious about the types of food they ate, Ample was delivering healthy and tasty meal replacements. Now Ample is starting to realize its potential – and raising again…
-
9
News Roundup: Gold’s $3,000 Target, Cannabis Sales Spike and More
I’ve been tracking several news stories this week. But there are four in particular that need further exploration… Bank of America hikes gold price target to $3,000: Bank of America is suddenly bullish on gold. It set an 18-month target of $3,000 in a report (shockingly) titled “The Fed Can’t Print Gold.” This is a surprisingly good analysis considering it’s…
-
10
Webinar: Meet the Founder of Illusio
There’s no such thing as a “sure bet” investment. But we’d like to invite you to hear from the founder of a very special company that comes as close as you can get to a sure bet. Even more remarkable, the company – Illusio – is an early-stage startup on the verge of upending a huge but outmoded market. The…
-
11
New Recommendation: A Startup Built for Our New Times
The investment opportunity I’m about to introduce you to is different from all my previous ones. Our economy and society have undergone enormous changes in the past few months as a result of the COVID-19 pandemic. And changing times require changing approaches. It’s not only about investing in “hypergrowth” anymore. Or investing in disruptive ideas or technology. What do those…
-
12
Webinar: New Crowdfunding Portal Comes Online
Specialized startup investment platforms or portals play an indispensable role in the crowdfunding ecosystem. Every time we recommend a startup to you, we tell you which portal it’s listed on. No portal, no recommendation. Portals also curate the startups that want to raise by rejecting those that don’t meet their standards. They identify “bad actors,” something the SEC requires them…
-
13
Invest in a Startup So Good, a Johnson & Johnson Subsidiary Is Partnering With It
I’m recommending you invest in this exceptional startup knowing you have other, more immediate concerns. But I also know that the novel coronavirus will fade into the background at some point, allowing you to better focus on your other needs. This is not the time to ignore those other needs. I understand that’s easier said than done. But with the…
-
14
Webinar: Ask This Startup Founder About His Move to COVID-19 Tests
One small startup is stepping up in the fight against COVID-19. You may have never heard of 20/20 GeneSystems. But members of our First Stage Investor research service have. We recommended they invest in 20/20 back in 2017. And now 20/20 is doing something we could not have predicted in 2017. This dynamic startup is gearing up to provide COVID-19…
-
15
Webinar: Ask 20/20 GeneSystems About Its Move to COVID-19 Tests
In the throes of a raging virus pandemic, one small startup is stepping up. First Stage Investor portfolio company 20/20 GeneSystems is gearing up to provide COVID-19 tests. As you may remember, 20/20’s main business (and why we recommended you invest in it in the first place) is layering artificial intelligence over the top of blood tests to help detect…
-
16
Where’s the Safe Haven?
The global economy is facing unprecedented challenges. We are simultaneously experiencing a demand shock, a supply shock, a stock market crisis and a debt crisis. Making things worse, we don’t know how long the COVID-19 crisis will last. The longer it lasts, the more severe the damage will be. It makes for a challenging investment environment, to say the least.…